Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 2378

1.

One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.

Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):512-9.

PMID:
16077421
2.

Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.

Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW.

Circulation. 2008 Sep 9;118(11):1146-54. doi: 10.1161/CIRCULATIONAHA.107.752147. Epub 2008 Aug 25.

3.

Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel.

Gruberg L, Milo S, Ben Tzvi M, Lotan C, Merin G, Braun S, Mohr R, Tzivoni D, Bitran D, Beyar R; Israel Arterial Revascularization Therapy Study Group.

Isr Med Assoc J. 2003 Aug;5(8):539-42.

4.

Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI).

Rodriguez A, Mele E, Peyregne E, Bullon F, Perez-Baliño N, Liprandi MI, Palacios IF.

J Am Coll Cardiol. 1996 Apr;27(5):1178-84.

5.
6.

Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.

Macaya C, Serruys PW, Ruygrok P, Suryapranata H, Mast G, Klugmann S, Urban P, den Heijer P, Koch K, Simon R, Morice MC, Crean P, Bonnier H, Wijns W, Danchin N, Bourdonnec C, Morel MA.

J Am Coll Cardiol. 1996 Feb;27(2):255-61.

7.

Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials.

Biondi-Zoccai GG, Abbate A, Agostoni P, Parisi Q, Turri M, Anselmi M, Vassanelli C, Zardini P, Biasucci LM.

Ital Heart J. 2003 Apr;4(4):271-80. Review.

PMID:
12784781
8.

Percutaneous versus surgical revascularization for multivessel coronary artery disease: a single center 10 year follow-up of SOS trial patients.

Buszman P, Wiernek S, Szymanski R, Bialkowska B, Buszman P, Fil W, Stables R, Bochenek A, Martin J, Tendera M.

Catheter Cardiovasc Interv. 2009 Sep 1;74(3):420-6. doi: 10.1002/ccd.22015.

PMID:
19360866
10.

Meta-analysis of 5-year outcomes of CABG vs PCI with stenting in patients with multivessel disease.

Athappan G, Vinodhkumaradithyaa A, Srinivasan M, Jeyaseelan L, Ponniah T.

Minerva Cardioangiol. 2008 Oct;56(5):453-60.

PMID:
18813180
11.

Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.

Reynolds MR, Neil N, Ho KK, Berezin R, Cosgrove RS, Lager RA, Sirois C, Johnson RG, Cohen DJ.

Am Heart J. 2003 Feb;145(2):334-42.

PMID:
12595853
13.

Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).

Rodriguez AE, Baldi J, Fernández Pereira C, Navia J, Rodriguez Alemparte M, Delacasa A, Vigo F, Vogel D, O'Neill W, Palacios IF; ERACI II Investigators.

J Am Coll Cardiol. 2005 Aug 16;46(4):582-8.

14.

Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators.

Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J, Vogel D, Grinfeld R, Delacasa A, Garrido M, Oliveri R, Mele E, Palacios I, O'Neill W.

J Am Coll Cardiol. 2001 Jan;37(1):51-8. Erratum in: J Am Coll Cardiol 2001 Mar 1;37(3):973-4.

15.

Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.

Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, Baumbach A, Angelini G, de Belder A, Oldroyd KG, Flather M, Roughton M, Nihoyannopoulos P, Bagger JP, Morgan K, Beatt KJ.

J Am Coll Cardiol. 2010 Feb 2;55(5):432-40. doi: 10.1016/j.jacc.2009.10.014.

16.

Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schönberger JP, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F.

J Am Coll Cardiol. 2005 Aug 16;46(4):575-81.

17.
19.
20.

Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.

Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, Sheiban I, Suttorp MJ, Vranckx P, Rademaker T, Goedhart D, Schuijer M, Wittebols K, Macours N, Stoll HP, Serruys PW; ARTS-II Investigators.

J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk